US Cannabis Sales Surge Past $2 Billion in February as Legal Market Rebounds
Advertisement
Legal cannabis stores across the United States generated $2.12 billion in sales during February 2026, marking a roughly 10 percent increase over the $1.97 billion sold in February 2025. The numbers signal a meaningful rebound for an industry that spent much of the past two years grappling with price compression, license contractions, and regulatory uncertainty. But beneath the headline figure, the state-by-state data reveals a market that's growing unevenly — with clear winners, persistent struggles, and emerging markets poised to reshape the national landscape.
Key Takeaways
- US legal cannabis sales hit $2.12 billion in February 2026, up approximately 10 percent year-over-year, with California ($296M), Michigan ($232M), and New York ($163M) leading the pack
- Total US cannabis sales are projected to reach $42 billion in 2026, with New York, Ohio, Minnesota, Virginia, and New Jersey identified as the top growth markets to watch
- New market maturation, state-level expansions, and anticipated federal rescheduling are driving the rebound, though falling prices and license contractions continue to squeeze operators
Table of Contents
- The Numbers: State-by-State Breakdown
- What's Driving the Rebound
- The Price Compression Problem Isn't Going Away
- Markets to Watch in 2026
- The $42 Billion Question
The Numbers: State-by-State Breakdown
California continues to lead the nation in raw cannabis revenue, posting $296 million in February sales. Despite years of complaints about overtaxation, illicit market competition, and regulatory burden, the Golden State's legal market remains the industry's center of gravity by a wide margin.
Michigan came in second at $232 million, though the state's market is under pressure from a new 24 percent wholesale tax that took effect in recent months. Monthly sales in Michigan actually fell to their lowest level in more than two years in February, suggesting that the tax burden is beginning to bite.
New York's legal market continues its rapid ascent, generating $163 million in February — a figure that would have been unthinkable just 18 months ago when the state's rollout was mired in litigation and licensing delays. The Empire State now ranks third nationally and is widely considered one of the top growth markets for 2026.
Florida, still operating as a medical-only market, posted $144 million in sales, while Massachusetts rounded out the top five at $130 million. Massachusetts' figure comes against the backdrop of a market where prices have dropped over 70 percent since 2018, pushing margins razor-thin for operators even as consumers benefit from lower costs.
At the other end of the spectrum, several smaller markets posted modest but growing numbers: Rhode Island ($8 million), Vermont ($9 million), Delaware ($10 million), and Utah ($15 million). These markets represent the early innings of legal cannabis adoption, with significant upside potential as retail infrastructure expands.
What's Driving the Rebound
The 10 percent year-over-year growth reverses a trend of slowing momentum that characterized much of 2024 and 2025. Several factors are converging to push the market upward.
New market maturation is the most significant driver. States like New York, which struggled with a chaotic launch, are finally reaching a critical mass of licensed retailers that makes legal cannabis genuinely accessible to most residents. New Jersey, Connecticut, and Maryland are following similar trajectories, with each month bringing new dispensary openings and expanded consumer awareness.
New state entries are also contributing. Kentucky opened its first medical cannabis dispensaries in early 2026, Minnesota's adult-use market is steadily expanding, and Virginia lawmakers just passed legislation to begin recreational sales in 2027. Each new state adds incremental revenue to the national total while also creating spillover effects in neighboring markets.
The pending federal rescheduling of cannabis from Schedule I to Schedule III [Quick Definition: A mid-level federal drug classification including ketamine and testosterone] has also injected optimism into the industry. While the regulatory change wouldn't legalize marijuana at the federal level, it would eliminate Section 280E [Quick Definition: IRS code barring cannabis businesses from deducting normal expenses like rent and payroll] — the IRS provision that prevents cannabis companies from deducting ordinary business expenses. For multi-state operators [Quick Definition: Cannabis companies licensed in multiple states], this could be the difference between operating at a loss and turning a profit.
The Price Compression Problem Isn't Going Away
Despite the encouraging top-line numbers, the cannabis industry's most persistent challenge — falling prices — continues to intensify. The average price of a gram of cannabis in Massachusetts has dropped to just above $4, down more than 70 percent since dispensaries first opened in 2018. Michigan, Oregon, and Colorado are experiencing similar dynamics, with wholesale prices in some markets barely covering production costs.
Price compression is a natural consequence of market maturation — more growers, more product, and more competition inevitably push prices down. But the cannabis industry faces a unique squeeze because federal illegality prevents operators from accessing normal business deductions, banking services, and interstate commerce. A company selling cannabis at $4 per gram while paying taxes on gross profit rather than net income faces a fundamentally different economic reality than one selling any other agricultural product.
The result is an industry where sales are rising but profitability remains elusive for many operators. The total number of active cannabis business licenses in the U.S. fell to 37,555 in the most recent quarter, extending a two-year decline of 13 percent. Companies are consolidating or closing, and the industry is increasingly bifurcating between well-capitalized multi-state operators and small businesses fighting for survival.
Markets to Watch in 2026
Industry analysts have identified five key growth states for 2026: New York, Ohio, Minnesota, Virginia, and New Jersey.
New York's trajectory is particularly dramatic. After a disastrous launch characterized by legal challenges, political infighting, and a massive illicit market, the state has turned a corner. With hundreds of licensed dispensaries now open and more in the pipeline, New York is projected to become a top-three cannabis market nationally by revenue within the next 12 to 18 months.
Ohio's adult-use market launched in August 2024 and is still in its growth phase, though a controversial new law (SB56) imposing a 35 percent THC cap on flower has created uncertainty. Minnesota is building its market from scratch with a unique regulatory framework that includes municipal government-run dispensaries — a model being watched closely by other states.
Virginia represents the next major market opportunity, with legislation now signed to begin recreational sales in 2027. The state's existing medical program and proximity to the massive Washington, D.C. metro area position it for rapid growth once retail infrastructure is in place.
The $42 Billion Question
Industry projections suggest that total U.S. cannabis sales could reach $42 billion in 2026, driven by the combination of new state launches, market maturation, and potential federal policy changes. The global recreational cannabis market is projected to hit $3.32 billion by 2030, with AI-enabled product innovation and cannabis beverages among the fastest-growing segments.
The February 2026 sales figures provide reason for cautious optimism. The market is growing, new states are opening, and federal policy is moving — slowly but unmistakably — in a more favorable direction. But the industry's structural challenges — price compression, 280E taxation, banking limitations, and a thriving illicit market — remain formidable obstacles.
For consumers, the trend is clearly positive: more stores, lower prices, better products, and expanding access. For operators and investors, the picture is more nuanced: a bigger market doesn't automatically mean a more profitable one, and the companies that thrive will be those that can navigate the gap between rising revenue and compressed margins.
Pull-Quote Suggestions:
"California continues to lead the nation in raw cannabis revenue, posting $296 million in February sales."
"Florida, still operating as a medical-only market, posted $144 million in sales, while Massachusetts rounded out the top five at $130 million."
"Legal cannabis stores across the United States generated $2.12 billion in sales during February 2026, marking a roughly 10 percent increase over the $1.97 billion sold in February 2025."
Why It Matters: US legal marijuana sales hit $2.12 billion in February 2026, up 10% year-over-year. See state-by-state data and what's driving the cannabis market rebound.